Company

Krystal Biotech ($KRYS)

  • Biotech

Overview

Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors for serious or rare diseases.

Part of the Pittsburgh ecosystem